UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 117.

Klein, K; Gay, R E; Gay, S (2016). Synoviale Fibroblasten : Hauptakteure bei der rheumatoiden Arthritis. Zeitschrift für Rheumatologie, 75(6):560-564.

Messemaker, T C; Frank-Bertoncelj, M; Marques, R B; Adriaans, A; Bakker, A M; Daha, N; Gay, S; Huizinga, T W; Toes, R E M; Mikkers, H M M; Kurreeman, F (2016). A novel long non-coding RNA in the rheumatoid arthritis risk locus TRAF1-C5 influences C5 mRNA levels. Genes and immunity, 17(2):85-92.

Gay, S (2015). Micro-RNA in der Pathogenese rheumatischer Erkrankungen. Drug Research, 65 Suppl:S18.

Ramming, A; Distler, J H W; Schett, G; Gay, S; Jüngel, A (2014). Epigenetische Modifikationen bei Autoimmunerkrankungen. Zeitschrift für Rheumatologie, 73(7):636-638.

Ospelt, C; Gay, S (2014). Epigenetik bei entzündlichen Systemerkrankungen. Der Internist, 55(2):124-127.

Brock, M; Samillan, V J; Trenkmann, M; Schwarzwald, C C; Ulrich, S; Gay, R E; Gassmann, M; Ostergaard, L; Gay, S; Speich, R; Huber, L C (2014). AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension. European Heart Journal, 35(45):3203-3211.

Niederer, F; Trenkmann, M; Ospelt, C; Karouzakis, E; Neidhart, M; Stanczyk, J; Kolling, C; Gay, R E; Detmar, M; Gay, S; Jüngel, A; Kyburz, D (2012). Downregulation of microRNA-34a* in rheumatoid arthritis synovial fibroblasts promotes apoptosis resistance. Arthritis and Rheumatism, 64(6):1771-1779.

Costenbader, K H; Gay, S; Riquelme, M E A; Iaccarino, L; Doria, A (2012). Genes, epigenetic regulation and environmental factors: Which is the most relevant in developing autoimmune diseases? Autoimmunity Reviews, 11(8):604-609.

Karouzakis, E; Gay, R E; Gay, S; Neidhart, M (2012). Increased recycling of polyamines is associated with global DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. Arthritis and Rheumatism, 64(6):1809-1817.

Yokota, K; Miyazaki, T; Hemmatazad, H; Gay, R E; Kolling, C; Fearon, U; Suzuki, H; Mimura, T; Gay, S; Ospelt, C (2012). The pattern-recognition receptor NOD1 promotes production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts. Arthritis and Rheumatism, 64(5):1329-1337.

Brock, M; Trenkmann, M; Filkova, M; Hemmatazad, H; Karouzakis, E; Niederer, F; Klein, K; Gay, S (2011). 7th meeting of the global arthritis research network. Arthritis Research & Therapy, 13:303.

Duroux-Richard, I; Presumey, J; Courties, G; Gay, S; Gordeladze, J; Jorgensen, C; Kyburz, D; Apparailly, F (2011). MicroRNAs as new player in rheumatoid arthritis. Joint, Bone, Spine, 78(1):17-22.

Bombardieri, M; Kam, N W; Brentano, F; Choi, K; Filer, A; Kyburz, D; McInnes, I B; Gay, S; Buckley, C; Pitzalis, C (2011). A BAFF/APRIL-dependent TLR3-stimulated pathway enhances the capacity of rheumatoid synovial fibroblasts to induce AID expression and Ig class-switching in B cells. Annals of the Rheumatic Diseases, 70(10):1857-1865.

Stanczyk, J; Ospelt, C; Karouzakis, E; Filer, A; Raza, K; Kolling, C; Gay, R; Buckley, C D; Tak, P P; Gay, S; Kyburz, D (2011). Altered expression of miR-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation. Arthritis and Rheumatism, 63(2):373-381.

Kollias, G; Papadaki, P; Apparailly, F; Vervoordeldonk, M J; Holmdahl, R; Baumans, V; Desaintes, C; Di Santo, J; Distler, J; Garside, P; Hegen, M; Huizinga, T W J; Jüngel, A; Klareskog, L; McInnes, I; Ragoussis, I; Schett, G; Hart, B; Tak, P P; Toes, R; van den Berg, W B; Wurst, W; Gay, S (2011). Animal models for arthritis: innovative tools for prevention and treatment. Annals of the Rheumatic Diseases, 70(8):1357-1362.

Karouzakis, E; Rengel, Y; Jüngel, A; Kolling, C; Gay, R E; Michel, B A; Tak, P P; Gay, S; Neidhart, M; Ospelt, C (2011). DNA methylation regulates the expression of CXCL12 in rheumatoid arthritis synovial fibroblasts. Genes and Immunity, 12(8):643-652.

György, B; Módos, K; Pállinger, E; Pálóczi, K; Pásztói, M; Misják, P; Deli, M A; Sipos, A; Szalai, A; Voszka, I; Polgár, A; Tóth, K; Csete, M; Nagy, G; Gay, S; Falus, A; Kittel, A; Buzás, E I (2011). Detection and isolation of cell-derived microparticles are compromised by protein complexes due to shared biophysical parameters. Blood, 117(4):e39.

Distler, J H W; Strapatsas, T; Huscher, D; Dees, C; Akhmetshina, A; Kiener, H P; Tarner, I H; Maurer, B; Walder, M; Michel, B; Gay, S; Smolen, J S; Müller-Ladner, U; Schett, G; Distler, O (2011). Dysbalance of angiogenic and angiostatic mediators in patients with mixed connective tissue disease. Annals of the Rheumatic Diseases, 70(7):1197-1202.

Karouzakis, E; Gay, R E; Gay, S; Neidhart, M (2011). Epigenetic deregulation in rheumatoid arthritis. In: Ballestar, E. Epigenetic Contributions in Autoimmune Disease. New York: Springer, 137-149.

Jüngel, A; Distler, J H W; Gay, S; Distler, O (2011). Epigenetic modifications: novel therapeutic strategies for systemic sclerosis? Expert Review of Clinical Immunology, 7(4):475-480.

Jüngel, A; Gay, S (2011). Epigentics in rheumatic diseases. Zeitschrift für Rheumatologie, 70(3):205-212.

Trenkmann, M; Brock, M; Gay, R E; Kolling, C; Speich, R; Michel, B A; Gay, S; Huber, L C (2011). Expression and function of EZH2 in synovial fibroblasts: epigenetic repression of the Wnt inhibitor SFRP1 in rheumatoid arthritis. Annals of the Rheumatic Diseases, 70(8):1482-1488.

Distler, J H W; Akhmetshina, A; Dees, C; Jüngel, A; Stürzl, M; Gay, S; Pisetsky, D S; Schett, G; Distler, O (2011). Induction of apoptosis in circulating angiogenic cells by microparticles. Arthritis and Rheumatism, 63(7):2067-2077.

Ospelt, C; Reedquist, K A; Gay, S; Tak, P P (2011). Inflammatory memories: Is epigenetics the missing link to persistent stromal cell activation in rheumatoid arthritis? Autoimmunity Reviews, 10(9):519-524.

Kurowska-Stolarska, M; Alivernini, S; Ballantine, L E; Asquith, D L; Millar, N L; Gilchrist, D S; Reilly, J; Ierna, M; Fraser, A R; Stolarski, B; McSharry, C; Hueber, A J; Baxter, D; Hunter, J; Gay, S; Liew, F Y; McInnes, I B (2011). MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 108(27):11193-11198.

Brock, M; Trenkmann, M; Gay, R E; Gay, S; Speich, R; Huber, L C (2011). MicroRNA-18a enhances the interleukin-6-mediated production of the acute-phase proteins fibrinogen and haptoglobin in human hepatocytes. Journal of Biological Chemistry, 286(46):40142-40150.

Yonekawa, K; Neidhart, M; Altwegg, L A; Wyss, C A; Corti, R; Vogl, T; Grigorian, M; Gay, S; Lüscher, T F; Maier, W (2011). Myeloid related proteins activate toll-like receptor 4 in human acute coronary syndromes. Atherosclerosis, 218(2):486-492.

Dees, C; Akhmetshina, A; Zerr, P; Reich, N; Palumbo, K; Horn, A; Jüngel, A; Beyer, C; Krönke, G; Zwerina, J; Reiter, R; Alenina, N; Maroteaux, L; Gay, S; Schett, G; Distler, O; Distler, J H W (2011). Platelet-derived serotonin links vascular disease and tissue fibrosis. Journal of Experimental Medicine, 208(5):961-972.

Niederer, F; Ospelt, C; Brentano, F; Hottiger, M O; Gay, R E; Gay, S; Detmar, M; Kyburz, D (2011). SIRT1 overexpression in the rheumatoid arthritis synovium contributes to proinflammatory cytokine production and apoptosis resistance. Annals of the Rheumatic Diseases, 70(10):1866-1873.

Senolt, L; Kryštůfková, O; Hulejová, H; Kuklová, M; Filková, M; Cerezo, L A; Běláček, J; Haluzík, M; Forejtová, S; Gay, S; Pavelka, K; Vencovsky, J (2011). The level of serum visfatin (PBEF) is associated with total number of B cells in patients with rheumatoid arthritis and decreases following B cell depletion therapy. Cytokine, 55(1):116-121.

Andrés Cerezo, L; Kuncová, K; Mann, H; Tomcik, M; Zámecník, J; Lukanidin, E; Neidhart, M; Gay, S; Grigorian, M; Vencovsky, J; Senolt, L (2011). The metastasis promoting protein S100A4 is increased in idiopathic inflammatory myopathies. Rheumatology, 50(10):1766-1772.

Kukita, A; Kukita, T; Nagata, K; Teramachi, J; Lin, Y J; Yoshida, H; Miyamoto, H; Gay, S; Pessler, F; Shobuike, T (2011). The transcription factor FBI-1/OCZF/LRF is expressed in osteoclasts and regulates RANKL-induced osteoclast formation in vitro and in vivo. Arthritis and Rheumatism, 63(9):2744-2754.

Jüngel, A; Gay, S (2011). miRNA in epigenetics of rheumatic diseases. Praxis, 100(1):37-43.

Neidhart, M; Karouzakis, E; Schumann, G G; Gay, R E; Gay, S (2010). Trex-1 deficiency in rheumatoid arthritis synovial fibroblasts. Arthritis and Rheumatism, 62(9):2673-2679.

Maciejewska Rodrigues, H; Karouzakis, E; Strietholt, S; Hemmatazad, H; Neidhart, M; Ospelt, C; Gay, R E; Michel, B A; Pap, T; Gay, S; Jüngel, A (2010). Epigenetics and rheumatoid arthritis: The role of SENP1 in the regulation of MMP-1 expression. Journal of Autoimmunity, 35(1):15-22.

Trenkmann, M; Brock, M; Ospelt, C; Gay, S (2010). Epigenetics in Rheumatoid Arthritis. Clinical Reviews in Allergy and Immunology, 39(1):10-19.

Senolt, L; Polanska, M; Filkova, M; Oslejskova, L; Pavelka, K; Gay, S; Haluzik, M; Vencovsky, J (2010). Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis. Annals of the Rheumatic Diseases, 69(7):1410-1411.

Jüngel, A; Ospelt, C; Lesch, M; Thiel, M A; Sunyer, T; Schorr, O; Michel, B A; Gay, R E; Kolling, C; Flory, C; Gay, S; Neidhart, M (2010). Effect of the oral application of a highly selective MMP-13 inhibitor in three different animal models of rheumatoid arthritis. Annals of the Rheumatic Diseases, 69(5):898-902.

Ospelt, C; Mertens, J C; Jüngel, A; Brentano, F; Maciejewska Rodrigues, H; Huber, L C; Hemmatazad, H; Wüest, T; Knuth, A; Gay, R E; Michel, B A; Gay, S; Renner, C; Bauer, S (2010). Inhibition of fibroblast activation protein and dipeptidylpeptidase 4 increases cartilage invasion by rheumatoid arthritis synovial fibroblasts. Arthritis and Rheumatism, 62(5):1224-1235.

Sudano, I; Flammer, A J; Périat, D; Enseleit, F; Hermann, M; Wolfrum, M; Hirt, A; Kaiser, P; Hurlimann, D; Neidhart, M; Gay, S; Holzmeister, J; Nussberger, J; Mocharla, P; Landmesser, U; Haile, S R; Corti, R; Vanhoutte, P M; Lüscher, T F; Noll, G; Ruschitzka, F (2010). Acetaminophen increases blood pressure in patients with coronary artery disease. Circulation, 122(18):1789-1796.

Frommer, K W; Zimmermann, B; Meier, F M P; Schröder, D; Heil, M; Schäffler, A; Büchler, C; Steinmeyer, J; Brentano, F; Gay, S; Müller-Ladner, U; Neumann, E (2010). Adiponectin-mediated changes in effector cells involved in the pathophysiology of rheumatoid arthritis. Arthritis and Rheumatism, 62(10):2886-2899.

Neumann, E; Riepl, B; Knedla, A; Lefèvre, S; Tarner, I H; Grifka, J; Steinmeyer, J; Schölmerich, J; Gay, S; Müller-Ladner, U (2010). Cell culture and passaging alters gene expression pattern and proliferation rate in rheumatoid arthritis synovial fibroblasts. Arthritis Research & Therapy, 12(3):R83.

Wyss, C A; Neidhart, M; Altwegg, L; Spanaus, K S; Yonekawa, K; Wischnewsky, M B; Corti, R; Kucher, N; Roffi, M; Eberli, F R; Amann-Vesti, B; Gay, S; von Eckardstein, Arnold; Lüscher, T F; Maier, W (2010). Cellular actors, Toll-like receptors, and local cytokine profile in acute coronary syndromes. European Heart Journal, 31(12):1457-1469.

Lu, Q; Renaudineau, Y; Cha, S; Ilei, G; Brooks, W H; Selmi, C; Tzioufas, A; Pers, J O; Bombardieri, S; Gershwin, M E; Gay, S; Youinou, P (2010). Epigenetics in autoimmune disorders: highlights of the 10th Sjögren's syndrome symposium. Autoimmunity Reviews, 9(9):627-630.

Maciejewska Rodrigues, H; Al-Shamisi, M; Hemmatazad, H; Ospelt, C; Bouton, M C; Jäger, D; Cope, A P; Charles, P; Plant, D; Distler, J H W; Gay, R E; Michel, B A; Knuth, A; Neidhart, M; Gay, S; Jüngel, A (2010). Functional autoantibodies against serpin E2 in rheumatoid arthritis. Arthritis and Rheumatism, 62(1):93-104.

Maurer, B; Stanczyk, J; Jüngel, A; Akhmetshina, A; Trenkmann, M; Brock, M; Kowal-Bielecka, O; Gay, R E; Michel, B A; Distler, J H W; Gay, S; Distler, O (2010). MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. Arthritis and Rheumatism, 62(6):1733-1743.

Neumann, E; Lefèvre, S; Zimmermann, B; Gay, S; Müller-Ladner, U (2010). Rheumatoid arthritis progression mediated by activated synovial fibroblasts. Trends in Molecular Medicine, 16(10):458-468.

Distler, O; Gay, S (2010). Sklerodermie. Der Internist, 51(1):30-38.

Ospelt, C; Gay, S (2010). TLRs and chronic inflammation. International Journal of Biochemistry & Cell Biology, 42(4):495-505.

Reich, N; Maurer, B; Akhmetshina, A; Venalis, P; Dees, C; Zerr, P; Palumbo, K; Zwerina, J; Nevskaya, T; Gay, S; Distler, O; Schett, G; Distler, J H W (2010). The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis. Arthritis and Rheumatism, 62(1):280-290.

Jüngel, A; Ospelt, C; Gay, S (2010). What can we learn from epigenetics in the year 2009? Current Opinion in Rheumatology, 22(3):284-292.

Oslejsková, L; Grigorian, M; Hulejová, H; Vencovsky, J; Pavelka, K; Klingelhöfer, J; Gay, S; Neidhart, M; Brabcová, H; Suchy, D; Senolt, L (2009). Metastasis-inducing S100A4 protein is associated with the disease activity of rheumatoid arthritis. Rheumatology, 48(12):1590-1594.

Maciejewska Rodrigues, H; Jüngel, A; Gay, R E; Gay, S (2009). Innate immunity, epigenetics and autoimmunity in rheumatoid arthritis. Molecular Immunology, 47(1):12-18.

Venalis, P; Maurer, B; Akhmetshina, A; Busch, N; Dees, C; Stürzl, M; Zwerina, J; Jüngel, A; Gay, S; Schett, G; Distler, O; Distler, J H W (2009). Lack of inhibititory effects of the anti-fibrotic drug imatinib on endothelial cell functions in vitro and in vivo. Journal of Cellular and Molecular Medicine, 13(10):4185-4191.

Guiducci, S; Distler, J H W; Milia, A F; Miniati, I; Rogai, V; Manetti, M; Falcini, F; Ibba-Manneschi, L; Gay, S; Distler, O; Matucci-Cerinic, M (2009). Stiff skin syndrome: evidence for an inflammation-independent fibrosis? Rheumatology, 48(7):849-852.

Meinecke, I; Pap, G; Mendoza, H; Drange, S; Ender, S; Strietholt, S; Gay, R E; Seyfert, C; Ink, B; Gay, S; Pap, T; Peters, M A (2009). Small ubiquitin-like modifier 1 [corrected] mediates the resistance of prosthesis-loosening fibroblast-like synoviocytes against Fas-induced apoptosis. Arthritis and Rheumatism, 60(7):2065-2070.

Brock, M; Trenkmann, M; Gay, R E; Michel, B A; Gay, S; Fischler, M; Ulrich, S; Speich, R; Huber, L C (2009). Interleukin-6 Modulates the Expression of the Bone Morphogenic Protein Receptor Type II Through a Novel STAT3-microRNA Cluster 17/92 Pathway. Circulation Research, 104(10):1184-11191.

Karouzakis, E; Gay, R E; Gay, S; Neidhart, M (2009). Epigenetic control in rheumatoid arthritis synovial fibroblasts. Nature Reviews. Rheumatology, 5(5):266-272.

Hemmatazad, H; Maciejewska Rodrigues, H; Maurer, B; Brentano, F; Pileckyte, M; Distler, J H W; Gay, R E; Michel, B A; Gay, S; Huber, L C; Distler, O; Jüngel, A (2009). Histone deacetylase 7, a potential target for the antifibrotic treatment of systemic sclerosis. Arthritis and Rheumatism, 60(5):1519-1529.

Beyer, C; Schett, G; Gay, S; Distler, O; Distler, J H W (2009). Hypoxia. Hypoxia in the pathogenesis of systemic sclerosis. Arthritis Research & Therapy, 11(2):220.

Senolt, L; Vencovský, J; Pavelka, K; Ospelt, C; Gay, S (2009). Prospective new biological therapies for rheumatoid arthritis. Autoimmunity Reviews, 9(2):102-107.

Warstat, K; Hoberg, M; Rudert, M; Tsui, S; Pap, T; Angres, B; Essl, M; Smith, T J; Cruikshank, W W; Klein, G; Gay, S; Aicher, W K (2009). TGF-{beta}1 and laminin-111 cooperate in the induction of IL-16 expression in synovial fibroblasts from rheumatoid arthritis patients. Annals of the Rheumatic Diseases, 69(1):270-275.

Knedla, A; Riepl, B; Lefèvre, S; Kistella, S; Grifka, J; Straub, R H; Gay, S; Schölmerich, J; Müller-Ladner, U; Neumann, E (2009). The therapeutic use of osmotic minipumps in the severe combined immunodeficiency (SCID) mouse model for rheumatoid arthritis. Annals of the Rheumatic Diseases, 68(1):124-129.

Brentano, F; Ospelt, C; Stanczyk, J; Gay, R E; Gay, S; Kyburz, D (2009). Abundant expression of the IL-23 subunit p19, but low levels of bioactive IL-23 in the rheumatoid synovium. Annals of the Rheumatic Diseases, 68(1):143-150.

Huber, L C; Soltermann, A; Fischler, M; Gay, S; Weder, W; Russi, E W; Speich, R; Ulrich, S (2009). Caveolin-1 Expression and Hemodynamics in COPD Patients. Open Respiratory Medicine Journal, 3:73-78.

Karouzakis, E; Gay, S; Michel, B A; Gay, R E; Neidhart, M (2009). DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. Arthritis and Rheumatism, 60(12):3613-3622.

Geyer, M; Grässel, S; Straub, R H; Schett, G; Dinser, R; Grifka, J; Gay, S; Neumann, E; Müller-Ladner, U (2009). Differential transcriptome analysis of intraarticular lesional vs intact cartilage reveals new candidate genes in osteoarthritis pathophysiology. Osteoarthritis and Cartilage, 17(3):328-335.

Distler, J H W; Beyer, C; Schett, G; Lüscher, T F; Gay, S; Distler, O (2009). Endothelial progenitor cells: Novel players in the pathogenesis of rheumatic diseases. Arthritis and Rheumatism, 60(11):3168-3179.

Neidhart, M; Baraliakos, X; Seemayer, C; Zelder, C; Gay, R E; Michel, B A; Boehm, H; Gay, S; Braun, J (2009). Expression of cathepsin K and MMP-1 indicate persistent osteodestruktive activity in longstanding ankylosing spondylitis. Annals of the Rheumatic Diseases, 68(8):1334-1339.

Ospelt, C; Brentano, F; Jüngel, A; Rengel, Y; Kolling, C; Michel, B A; Gay, R E; Gay, S (2009). Expression, regulation, and signaling of the pattern-recognition receptor nucleotide-binding oligomerization domain 2 in rheumatoid arthritis synovial fibroblasts. Arthritis and Rheumatism, 60(2):355-363.

Sellam, J; Proulle, V; Jüngel, A; Ittah, M; Miceli Richard, C; Gottenberg, J E; Toti, F; Benessiano, J; Gay, S; Freyssinet, J M; Mariette, X (2009). Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Arthritis Research & Therapy, 11(5):R156.

Filková, M; Lisková, M; Hulejová, H; Haluzík, M; Gatterová, J; Pavelková, A; Pavelka, K; Gay, S; Müller-Ladner, U; Senolt, L (2009). Increased serum adiponectin levels in female patients with erosive compared with non-erosive osteoarthritis. Annals of the Rheumatic Diseases, 68(2):295-296.

Kurowska-Stolarska, M; Distler, J H; Jüngel, A; Rudnicka, W; Neumann, E; Pap, T; Wenger, R H; Michel, B A; Müller-Ladner, U; Gay, R E; Maslinski, W; Gay, S; Distler, O (2009). Inhibitor of DNA binding/differentiation 2 induced by hypoxia promotes synovial fibroblast-dependent osteoclastogenesis. Arthritis and Rheumatism, 60(12):3663-3675.

Müller-Ladner, U; Distler, O; Ibba-Manneschi, L; Neumann, E; Gay, S (2009). Mechanisms of vascular damage in systemic sclerosis. Autoimmunity, 42(7):587-595.

Hayer, S; Pundt, N; Peters, M A; Wunrau, C; Kühnel, I; Neugebauer, K; Strietholt, S; Zwerina, J; Korb, A; Penninger, J; Joosten, L A; Gay, S; Rückle, T; Schett, G; Pap, T (2009). PI3K{gamma} regulates cartilage damage in chronic inflammatory arthritis. FASEB Journal, 23(12):4288-4298.

Lefèvre, S; Knedla, A; Tennie, C; Kampmann, A; Wunrau, C; Dinser, R; Korb, A; Schnäker, E M; Tarner, I H; Robbins, P D; Evans, C H; Stürz, H; Steinmeyer, J; Gay, S; Schölmerich, J; Pap, T; Müller-Ladner, U; Neumann, E (2009). Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nature Medicine, 15(12):1414-1420.

Maurer, B; Walder, M; Gay, R E; Gay, S; Distler, O (2009). Systemische Sklerose: Zielkriterien der Behandlung. Zeitschrift für Rheumatologie, 68(1):37-43.

Huber, L C; Jüngel, A; Gay, S (2009). Targeting the epigenetic modifications of synovial cells. In: Tak, P P. New Therapeutic Targets in Rheumatoid Arthritis. Basel, Switzerland: Birkhauser / Springer, 193-206.

Filková, M; Haluzík, M; Gay, S; Senolt, L (2009). The role of resistin as a regulator of inflammation: Implications for various human pathologies. Clinical Immunology, 133(2):157-170.

Brentano, F; Kyburz, D; Gay, S (2009). Toll-like receptors and rheumatoid arthritis. In: O'Neill, L A J; McCoy, C E. Toll-Like Receptors. Heidelberg / New York: Humana Press, 329-343.

Maurer, B; Busch, N; Jüngel, A; Pileckyte, M; Gay, R E; Michel, B A; Schett, G; Gay, S; Distler, J; Distler, O (2009). Transcription factor Fos-Related Antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosis. Circulation, 120(23):2367-2376.

Stanczyk, J; Pedrioli, D M L; Brentano, F; Sanchez-Pernaute, O; Kolling, C; Gay, R E; Detmar, M; Gay, S; Kyburz, D (2008). Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis and Rheumatism, 58(4):1001-1009.

Flammer, A J; Sudano, I; Hermann, F; Gay, S; Forster, A; Neidhart, M; Künzler, P; Enseleit, F; Périat, D; Hermann, M; Nussberger, J; Luscher, T F; Corti, R; Noll, G; Ruschitzka, F (2008). Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis. Circulation, 117(17):2262-2269.

Warstat, K; Pap, T; Klein, G; Gay, S; Aicher, W K (2008). Co-activation of synovial fibroblasts by laminin-111 and transforming growth factor-beta induces expression of matrix metalloproteinases 3 and 10 independently of nuclear factor-{kappa}B. Annals of the Rheumatic Diseases, 67(4):559-62.

Reisch, N; Engler, A; Aeschlimann, A; Simmen, B R; Michel, B A; Gay, R E; Gay, S; Sprott, H (2008). DREAM is reduced in synovial fibroblasts of patients with chronic arthritic pain: is it a suitable target for peripheral pain management? Arthritis Research & Therapy, 10(3)::1-8.

Akhmetshina, A; Dees, C; Pileckyte, M; Maurer, B; Axmann, R; Jüngel, A; Zwerina, J; Gay, S; Schett, G; Distler, O; Distler, J H W (2008). Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis. FASEB Journal, 22(7):2214-2222.

Huber, L C; Künzler, P; Boyce, S H; Michel, B A; Gay, R E; Ink, B S; Gay, S (2008). Effects of a novel tyrosine kinase inhibitor in rheumatoid arthritis synovial fibroblasts. Annals of the Rheumatic Diseases, 67(3):389-394.

Sánchez-Pernaute, O; Ospelt, C; Neidhart, M; Gay, S (2008). Epigenetic clues to rheumatoid arthritis. Journal of Autoimmunity, 30(1-2):12-20.

Strietholt, S; Maurer, B; Peters, M A; Pap, T; Gay, S (2008). Epigenetic modifications in rheumatoid arthritis. Arthritis Research & Therapy, 10 (5):1-9.

Aicher, W K; Pap, T; Gay, S (2008). Laminin-modulierte Entzündungsreaktionen in synovialen Fibroblasten von Rheumapatienten. Zeitschrift für Rheumatologie, 67(1):59-61.

Drees, P; Eckardt, A; Gay, R E; Gay, S; Huber, L C (2008). Molekulare Signalwege der aseptischen Endoprothesenlockerung (Molecular pathways in aseptic loosening of orthopaedic endoprosthesis). Biomedizinische Technik. Biomedical Engineering, 53(3):93-103.

Ospelt, C; Brentano, F; Rengel, Y; Stanczyk, J; Kolling, C; Tak, P P; Gay, S; Gay, R E; Kyburz, D (2008). Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: Toll-like receptor expression in early and longstanding arthritis. Arthritis and Rheumatism, 58(12):3684-3692.

Pessler, F; Ogdie, A; Diaz-Torne, C; Dai, L; Yu, X; Einhorn, E; Gay, S; Schumacher, H R (2008). Subintimal Ki-67 as a synovial tissue biomarker for inflammatory arthropathies. Annals of the Rheumatic Diseases, 67(2):162-167.

Distler, J H W; Schett, G; Gay, S; Distler, O (2008). The controversial role of tumor necrosis factor alpha in fibrotic diseases. Arthritis and Rheumatism, 58(8):2228-2235.

Ospelt, C; Kurowska-Stolarska, M; Neidhart, M; Michel, B A; Gay, R E; Laufer, S; Gay, S (2008). The dual inhibitor of lipoxygenase and cyclooxygenase ML3000 decreases the expression of CXCR3 ligands. Annals of the Rheumatic Diseases, 67(4):524-529.

Oslejsková, L; Grigorian, M; Gay, S; Neidhart, M; Senolt, L (2008). The metastasis associated protein S100A4: a potential novel link to inflammation and consequent aggressive behaviour of rheumatoid arthritis synovial fibroblasts. Annals of the Rheumatic Diseases, 67(11):1499-1504.

Guiducci, S; Distler, J H W; Jüngel, A; Huscher, D; Huber, L C; Michel, B A; Gay, R E; Pisetsky, D S; Gay, S; Matucci-Cerinic, M; Distler, O (2008). The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis. Arthritis and Rheumatism, 58(9):2845-2853.

Ospelt, C; Gay, S (2008). The role of resident synovial cells in destructive arthritis. Best Practice & Research: Clinical Rheumatology, 22(2):239-252.

Brentano, F; Schorr, O; Ospelt, C; Stanczyk, J; Gay, R E; Gay, S; Kyburz, D (2007). Pre-B cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities. Arthritis and Rheumatism, 56(9):2829-2839.

Huber, L C; Distler, J H W; Moritz, F; Hemmatazad, H; Hauser, T; Michel, B A; Gay, R E; Matucci-Cerinic, M; Gay, S; Distler, O; Jüngel, A (2007). Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis. Arthritis and Rheumatism, 56(8):275-264.

Hoberg, M; Rudert, M; Pap, T; Klein, G; Gay, S; Aicher, W K (2007). Attachment to laminin-111 facilitates transforming growth factor beta-induced expression of matrix metalloproteinase-3 in synovial fibroblasts. Annals of the Rheumatic Diseases, 66(4):446-451.

Meinecke, I; Cinski, A; Baier, A; Peters, M A; Dankbar, B; Wille, A; Drynda, A; Mendoza, H; Gay, R E; Hay, R T; Ink, B; Gay, S; Pap, T (2007). Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 104(12):5073-5078.

Huber, L C; Jüngel, A; Distler, J H W; Moritz, F; Gay, R E; Michel, B A; Pisetsky, D S; Gay, S; Distler, O (2007). The role of membrane lipids in the induction of macrophage apoptosis by microparticles. Apoptosis, 12(2):363-374.

Distler, J H W; Jüngel, A; Huber, L C; Schulze-Horsel, U; Zwerina, J; Gay, R E; Michel, B A; Hauser, T; Schett, G; Gay, S; Distler, O (2007). Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis. Arthritis and Rheumatism, 56(1):311-322.

Huber, L C; Moritz, F; Gay, S (2007). Spondylarthritides and related entities: entheses and hypotheses. Arthritis and Rheumatism, 56(1):4-8.

Flammer, A J; Hermann, F; Wiesli, P; Schwegler, B; Chenevard, R; Hurlimann, D; Sudano, I; Gay, S; Neidhart, M; Riesen, W; Ruschitzka, F; Lüscher, T F; Noll, G; Lehmann, R (2007). Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension. Journal of Hypertension, 25(4):785-791.

Sprott, H; Gay, R E; Michel, B A; Gay, S (2006). Influence of ibuprofen-arginine on serum levels of nitric oxide metabolites in patients with chronic low back pain--a single-blind, placebo controlled pilot trial (ISRCTN18723747). The Journal of Rheumatology, 33(12):2515-2518.

Huber, L C; Distler, O; Gay, R E; Gay, S (2006). Antisense strategies in degenerative joint diseases: sense or nonsense? Advanced Drug Delivery Reviews, 58(2):285-299.

Steffel, J; Hermann, M; Greutert, H; Gay, S; Lüscher, T F; Ruschitzka, F; Tanner, F C (2005). Celecoxib decreases endothelial tissue factor expression through inhibition of c-Jun terminal NH2 kinase phosphorylation. Circulation, 111(13):1685-1689.

Distler, J H W; Jüngel, A; Huber, L C; Seemayer, C A; Reich, C F; Gay, R E; Michel, B A; Fontana, A; Gay, S; Pisetsky, D S; Distler, O (2005). The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 102(8):2892-2897.

Distler, J H W; Wenger, R H; Gassmann, M; Kurowska, M; Hirth, A K; Gay, S; Distler, O (2004). Physiologic responses to hypoxia and implications for hypoxia-inducible factors in the pathogenesis of rheumatoid arthritis. Arthritis and Rheumatism, 50(1):10-23.

Machner, A; Baier, A; Wille, A; Drynda, S; Pap, G; Drynda, A; Mawrin, C; Bühling, F; Gay, S; Neumann, W; Pap, T (2003). Higher susceptibility to Fas ligand induced apoptosis and altered modulation of cell death by tumor necrosis factor-alpha in periarticular tenocytes from patients with knee joint osteoarthritis. Arthritis Research & Therapy, 5(5):R253-R261.

Pap, T; Claus, A; Ohtsu, S; Hummel, K M; Schwartz, P; Drynda, S; Pap, G; Machner, A; Stein, B; George, M; Gay, R E; Neumann, W; Gay, S; Aicher, W K (2003). Osteoclast-independent bone resorption by fibroblast-like cells. Arthritis Research & Therapy, 5(3):R163-R173.

Seemayer, C A; Kolb, S A; Neidhart, M; Ohshima, S; Gay, R E; Michel, B A; Gay, S; Böni, J; Schüpbach, J (2002). Absence of inducible retroviruses from synovial fibroblasts and synovial fluid cells of patients with rheumatoid arthritis. Arthritis and Rheumatism, 46(16):2811-2813.

Distler, O; Del Rosso, A; Giacomelli, R; Cipriani, P J; Conforti, M L; Guiducci, S G; Gay, R E; Michel, B A; Brühlmann, P; Müller-Ladner, U; Gay, S; Matucci-Cerinic, M (2002). Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Arthritis Research, 4(6):R11-10.

Pap, T; Gay, R E; Müller-Ladner, U; Gay, S (2002). Ex vivo gene transfer in the years to come. Arthritis Research, 4:10.

Masuda, K; Masuda, R; Neidhart, M; Simmen, B R; Michel, B A; Müller-Ladner, U; Gay, R E; Gay, S (2002). Molecular profile of synovial fibroblasts in rheumatoid arthritis depends on the stage of proliferation. Arthritis Research, 4:R8.

This list was generated on Wed Jul 26 23:21:58 2017 CEST.